Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma

Area of Science:

• Neuro-oncology
• Vascular Biology
• Cancer Biology

Background:

• Glioblastoma (GBM) is a highly vascularized brain tumor.
• Tumor growth and progression depend on angiogenesis, the formation of new blood vessels.
• Existing treatments have limited efficacy, necessitating novel therapeutic strategies.

Purpose of the Study:

• To review molecular mediators regulating GBM angiogenesis.
• To summarize recent clinical research on anti-angiogenesis strategies for GBM.
• To highlight the potential of targeting angiogenic pathways in GBM treatment.

Main Methods:

• Literature review of molecular mediators of GBM angiogenesis.
• Analysis of recent clinical studies on anti-angiogenesis therapies for GBM.
• Synthesis of information on exploiting angiogenic pathways for GBM treatment.

Main Results:

• Several molecular factors and genes stimulate glioma angiogenesis.
• Anti-angiogenesis therapy aims to inhibit tumor vascularization.
• Targeting angiogenic pathways shows potential in preclinical and clinical settings.

Conclusions:

• Understanding GBM angiogenesis is crucial for effective treatment.
• Anti-angiogenesis represents a key therapeutic strategy for GBM.
• Further research into molecular mediators can optimize GBM treatment outcomes.